tetramethylpyrazine has been researched along with Cardiac Failure in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, M; Jiang, M; Li, Y; Lian, N; Meng, Q; Tong, J; Zhu, W | 1 |
| Guo, L; Sun, Y; Wang, A; Xu, C | 1 |
| Chen, L; Deng, YL; Du, J; Huang, H; Lin, YZ; Xu, CX | 1 |
| Cui, LH; Duan, SF; Peng, W | 1 |
4 other study(ies) available for tetramethylpyrazine and Cardiac Failure
| Article | Year |
|---|---|
Ligustrazine and liguzinediol protect against doxorubicin-induced cardiomyocytes injury by inhibiting mitochondrial apoptosis and autophagy.
Topics: Animals; Apoptosis; Autophagy; Doxorubicin; Heart Failure; Myocytes, Cardiac; Rats | 2023 |
Evaluation of antioxidant and immunity function of tetramethylpyrazine phosphate tablets in vivo.
Topics: Animals; Antioxidants; Blood Pressure; Body Weight; Cardiotonic Agents; Catalase; Glutathione Peroxidase; Heart; Heart Failure; Interleukin-6; Isoproterenol; Malondialdehyde; Organ Size; Organophosphates; Oxidative Stress; Pyrazines; Rats; Rats, Wistar; Superoxide Dismutase; Tablets; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2012 |
[Effects of tetramethylpyrazine on fibrosis of atrial tissue and atrial fibrillation in a canine model of congestive heart failure induced by ventricular tachypacing].
Topics: Animals; Atrial Fibrillation; Cardiac Pacing, Artificial; Dogs; Female; Fibrosis; Heart Atria; Heart Failure; Male; Pyrazines; Random Allocation | 2006 |
Effects of sustained ligustrazine on hemorrheology in patients with chronic pulmonary heart disease.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aged, 80 and over; Blood Viscosity; Female; Fibrinolytic Agents; Heart Failure; Hematocrit; Humans; Male; Middle Aged; Pulmonary Heart Disease; Pyrazines; Thromboxane B2 | 1992 |